Navigation Links
diaDexus, Inc. Highlights Findings from Two Outcomes Studies for its PLAC Lp-PLA(2) Activity Assay
Date:3/19/2012

clinical studies; diaDexus' high degree of customer concentration, including the downward pressure that its largest customers may be able to exert on its product pricing; diaDexus' relationship with key customers, including GlaxoSmithKline, the licensor of Lp-PLA(2); diaDexus' reliance on a sole source third party manufacturer to manufacture and supply diaDexus' PLAC® ELISA Test; third party payors' acceptance of and reimbursement for the PLAC® Test; diaDexus' ability to develop and commercialize new products and services; various risks associated with the international expansion of diaDexus' business; diaDexus' ability to successfully launch and commercialize the PLAC® Test for Lp-PLA(2) Activity in Europe, and its dependence on its distributors for foreign sales of that test; diaDexus' ability to initiate and continue to manufacture the PLAC® Test for Lp-PLA(2) Activity at its facility in South San Francisco, California; the adequacy of diaDexus' intellectual property rights; diaDexus' ability to satisfy its obligations under its license agreements, to maintain its license rights under those license agreements and to enter into any necessary licenses on acceptable terms; diaDexus' ability to attract, retain and motivate qualified personnel; the effects of U.S. and foreign government regulations and diaDexus' ability to comply with such regulations; diaDexus' limited revenue and cash resources; and diaDexus' significant corporate expenses, including real estate lease liabilities and expenses associated with being a public company. Additional factors that could cause diaDexus' results to differ materially from those described in the forward-looking statements can be found in diaDexus' most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q and other reports filed with the Securities and Exchange Commission, and available at the SEC's web site at www.sec.gov. The information set forth
'/>"/>
SOURCE diaDexus, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. diaDexus, Inc. Reports 2011 Fourth Quarter and Year-End Financial Results
2. diaDexus, Inc. to Host Webcast March 15, 2012 on 2011 Fourth Quarter and Year-End Financial Results
3. diaDexus, Inc. Reports 38% Year-Over-Year Revenue Growth for 2011 Third Quarter
4. diaDexus, Inc. Reports 2011 First Quarter Financial Results
5. diaDexus, Inc. Reports 2010 Third Quarter Financial Results
6. diaDexus, Inc. Adds Two New Directors; Corporate Overview & 3Q Results Webcast Set for November 16, 2010
7. Elekta Highlights Latest Version of MOSAIQ Oncology Information System at HIMSS12 Meeting
8. Bionovo to Host Conference Call to Discuss 2011 Highlights and Year-End Financial Results
9. UBM Medicas Musculoskeletal Network Highlights Key Orthopedic Findings From AAOS
10. Zacks Voice of the People highlights opportunities with Walgreen, Occidental Petroleum and Brown & Brown
11. Ampio Pharmaceuticals Reports Full-Year 2011 Financial Results and Milestone Highlights for 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... MOUNTAIN VIEW, Calif. , July 23, ... in translational preclinical research, today unveiled their new logo ... the transformation of Surpass, corporate culture to one where ... customers. This press release comes on the heels of ... added to the Silicon Valley Team:  David Craig, a ...
(Date:7/23/2014)... Ill. , July 23, 2014 ... IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY ... THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. ... 2014 financial results on Friday, July 25, 2014, before the ... of the earnings conference call at 8 a.m. Central time ...
(Date:7/23/2014)... 2014  RT Oncology Services Corporation today announced that ... board of directors. Mr. Mundie is currently senior advisor ... on strategic projects within the company and on technology ... and strategy officer. Mike Martin ... "Craig is a visionary technology executive. His appointment is ...
Breaking Medicine Technology:SURPASS Launches New Company Logo and Corporate Website, Symbolizing Transformation of Company Culture to Meet the Changing Needs of Clients in the Life Science Community Today. 2SURPASS Launches New Company Logo and Corporate Website, Symbolizing Transformation of Company Culture to Meet the Changing Needs of Clients in the Life Science Community Today. 3AbbVie to Host Second-Quarter Earnings Conference Call 2AbbVie to Host Second-Quarter Earnings Conference Call 3AbbVie to Host Second-Quarter Earnings Conference Call 4AbbVie to Host Second-Quarter Earnings Conference Call 5AbbVie to Host Second-Quarter Earnings Conference Call 6Craig Mundie Joins RainTree Oncology Board of Directors 2Craig Mundie Joins RainTree Oncology Board of Directors 3
... In Children,s DNA, a Hint of a Mutation,s Ancestral ... researchers,seeking to replicate another group,s discovery of an important ... a particular,variant in DNA that may be more helpful ... populations worldwide. The finding suggests that,the gene variant, identified ...
... ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ) announced ... clinical study of ANX-510, CoFactor(R), for the treatment ... at the 2008,American Society of Clinical Oncology (ASCO) ... 3, 2008 in Chicago, IL., The poster ...
Cached Medicine Technology:Gene Hunters Fine-Tune Marker for Common Obesity Gene 2Gene Hunters Fine-Tune Marker for Common Obesity Gene 3ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO) 2ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO) 3
(Date:7/23/2014)... China,s Northwest Agricultural and Forestry University in Shaanxi province, ... memorandum of agreement that lays the groundwork for establishing ... China. , The signing ceremony was held in the ... officials of the U.S. Department of Agriculture and China,s ... a landmark event for UC Davis and for our ...
(Date:7/23/2014)... Angeles, CA (PRWEB) July 23, 2014 ... practices delivering Enhanced External Counterpulsation (EECP), is ... who receives EECP therapy at the health center. ... ischemic heart disease. Since receiving ongoing EECP therapy since ... , When Sara Soulati, CEO of Global Cardio Care, ...
(Date:7/23/2014)... Unlocking the secrets to better treating the pernicious disorders ... to a paper from American University,s Center for Behavioral ... treating obesity with therapies aimed at areas of the ... focus on the hippocampus could play a role in ... diseases, therapies and preventive measures often fall short. This ...
(Date:7/23/2014)... HealthDay Reporter WEDNESDAY, July 23, ... an additional side benefit -- it may improve urinary ... The study found that nearly half of women ... to the procedure. After surgery, most of those women ... study researcher Dr. Leslee Subak, professor of obstetrics, gynecology ...
(Date:7/23/2014)... catalog the molecular causes of stomach cancer, scientists, ... four subtypes of tumors based on shared mutations ... classification promises to advance clinical research to develop ... , In a report in Nature , ... said they analyzed 295 samples of gastric (stomach) ...
Breaking Medicine News(10 mins):Health News:Global food safety research agreement signed by China and UC Davis 2Health News:Global food safety research agreement signed by China and UC Davis 3Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2Health News:Targeting the brain to treat obesity 2Health News:Targeting the brain to treat obesity 3Health News:Weight Loss Surgery May Help Ease Urinary Incontinence 2Health News:Weight Loss Surgery May Help Ease Urinary Incontinence 3Health News:New view of stomach cancer could hasten better therapies 2Health News:New view of stomach cancer could hasten better therapies 3
... in low sunlight areas are more likely to experience ... same environment. Researchers believe that these findings should change ... study shows that across the board vitamin D recommendations ... M.D., M.B.A., clinical instructor in the department of urology ...
... well-known risk factor for heart disease. Researchers at the ... participated in an international study of 200,000 Europeans which ... pressure. The discovery, presented in Nature, is an important ... people worldwide suffer from high blood pressure and are ...
... in areas with low sunlight are up to 3 ... men and should take high levels of Vitamin D supplements, ... of Medicine. "This study shows that the current ... Vitamin D don,t work," said Adam Murphy, M.D., a clinical ...
... Tenn. September 19, 2011) The largest study ever of ... tumors carried extra copies of specific genes linked to cancer ... Hospital investigators. The findings identify possible new targets ... diffuse intrinsic pontine glioma (DIPG). Current survival rates for children ...
... , MONDAY, Sept. 19 (HealthDay News) -- Obese 8- ... than their normal-weight peers, a new study finds. In ... of height and weight, at ages 4 and 5 and ... out questionnaires that assessed children,s mental health and health-related quality ...
... HealthDay Reporter , MONDAY, Sept. 19 (HealthDay News) -- ... treating varicose veins, it appears that recurrence of one ... laser treatment, German researchers report. Varicose veins are ... legs. As many as 35 percent of adults suffer ...
Cached Medicine News:Health News:African-American men living in poor sunlight areas at risk for vitamin D deficiency 2Health News:Genetic factors behind high blood pressure 2Health News:One size doesn't fit all for vitamin D and men 2Health News:Key regulatory genes often amplified in aggressive childhood tumor of the brainstem 2Health News:Key regulatory genes often amplified in aggressive childhood tumor of the brainstem 3Health News:Obese Kids May Face Social, Emotional Woes 2Health News:Obese Kids May Face Social, Emotional Woes 3Health News:Two Varicose Veins Treatments Equally Effective 2Health News:Two Varicose Veins Treatments Equally Effective 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: